We live in a world where being medicated has become a societal norm. Modern health care practices have set the stage for the proliferation of direct-to-consumer advertising (DTCA) of prescription drugs by pharmaceutical manufacturers. Some of these practices include the emergence of managed care organizations (MCOs), the legalization of DTCA of prescription drugs, the emergence of the Internet as an alternative promotional channel, the increased desire by patients to become more involved in their own health care decisions, the disillusionment with traditional medicine, and the rise of ‘alternative’ medicine, to name a few. There is an ongoing debate as to the ultimate harm or benefit of this relatively recent practice of pharmaceutical manufacturers to direct their promotional efforts away from the physician and towards the consumer.
With the ongoing expansion of technology, being “at risk” has become a common diagnosis that requires its own cycle of prescriptions and treatments. It’s almost like biomedicalization has become a disease like state in itself. Fosket uses this perspective to analyze the emergence of pharmaceuticals as credible strategies for breast cancer prevention and the analogous emergence of a group of women designated “high risk” for breast cancer and targeted for pharmaceutical interventions. These interventions include Chemoprevention, which is “the practice of ingesting pharmaceuticals or nutraceuticals to prevent disease” (Fosket 331). This practice of Chemoprevention was also seen in many articles we read this semester, some of which is Dumit’s “Pharmaceutical Witnessing and Direct-to-Consumer Advertising”, where he mentions how people may experience things that may not be pathological, like heart burn, b...
... middle of paper ...
...ars to be the most promising agent in primary prevention of breast cancer. It changed the way prevention is perceived by biomedicalizing it. Prevention is seen as equivalent to risk reduction. Also, it is the only United States Food and Drug Administration (US FDA) approved drug for reducing breast cancer risk in high-risk women. Promising as it may seem, the scope of primary prevention has been restricted to women at high risk of developing breast cancer because of inherent limitations of these strategies. Knowledge is power, “The lack of knowledge in the realm of breast cancer prevention makes for greater investment in chemoprevention”. Owing to failure of etiologic studies in breast cancer research to identify primary prevention strategies suitable for the general population, reducing mortality through early detection of breast cancer still remains the mainstay.
In Melody Peterson’s “Our Daily Meds” , the history of marketing and advertising in the pharmaceutical industry is explored. The first chapter of the book, entitled “Creating disease”, focuses on how major pharmaceutical companies successfully create new ailments that members of the public believe exist. According to Peterson, the success that these drug manufacturers have experienced can be attributed to the malleability of disease, the use of influencial people to promote new drugs, the marketing behind pills, and the use of media outlets.
Direct-to-consumer (DTC) marketing of pharmaceuticals has grown increasingly in the past decade. The American public views prescription drug advertising for a wide range of medical conditions, including high cholesterol, depression, allergies, and erectile dysfunction. The Federal Food and Drug Administration (FDA) regulates the content of these advertisements. Critics also have taken the position that the advertisements garner unearned trust from the public, are misleading, and promote unnecessary use of prescription drugs for common problems associated with aging. Proponents counter that DTC ads help eliminate stigmas associated with certain medical conditions, give patients an active role in their health care management, and encourages the doctor/patient relationship. There have been calls for bans on DTC pharmaceutical advertising, but the practice is protected under a business’s right to free speech. Regulation changes, particularly requiring the FDA to pre-approve marketing campaigns before they are released to the public, may be one way to appease opponents, while protecting the rights of pharmaceutical manufacturers to advertise to the average American consumer.
"In the past two decades or so, health care has been commercialized as never before, and professionalism in medicine seems to be giving way to entrepreneurialism," commented Arnold S. Relman, professor of medicine and social medicine at Harvard Medical School (Wekesser 66). This statement may have a great deal of bearing on reality. The tangled knot of insurers, physicians, drug companies, and hospitals that we call our health system are not as unselfish and focused on the patients' needs as people would like to think. Pharmaceutical companies are particularly ruthless, many of them spending millions of dollars per year to convince doctors to prescribe their drugs and to convince consumers that their specific brand of drug is needed in order to cure their ailments. For instance, they may present symptoms that are perfectly harmless, and lead potential citizens to believe that, because of these symptoms, they are "sick" and in need of medication. In some instances, the pharmaceutical industry in the United States misleads both the public and medical professionals by participating in acts of both deceptive marketing practices and bribery, and therefore does not act within the best interests of the consumers.
First, when viewing DTC prescription drug ads, the public cannot understand the wording used to describe the drugs. Because of this, the producers of these ads are able to manipulate the drug’s effects to sway people into buying them. According to the article, 74% of surveyed doctors believe that the benefits expressed in prescription drug ads are embellished (paragraph 5). This inaccurate information causes patients to be misinformed as to the effects of the drug. Opposingly, 48% of doctors state that these ads inform and educate patients about DTC prescription drugs (paragraph 6). The percentages
DTC advertisements aim to persuade that their possibly less effective drugs work better than other drugs rather than to inform consumers of correct information about drugs. The reason that pharmaceutical companies abuse the power of DTC advertising is because the pharmaceutical industry does not have a strong ethical code for advertising; their sales are so obsessed with profits. To solve this problem, policy makers should prohibit indiscreet DTC advertisements on air and fund more informative services about new drugs so that patients could make clever
In Melody Peterson’s “Our Daily Meds” , the history of marketing and advertising in the pharmaceutical industry is explored. The first chapter of the book, entitled “Creating disease”, focuses on how major pharmaceutical companies successfully create new ailments that members of the public believe exist. According to Peterson, the success that these drug manufacturers have experienced can be attributed to the malleability of disease, the use of influencial people to promote new drugs and the efficient usage of media outlets.
More than often, American’s argue that if we have the technology to gain access to these “miracle meds”, then we should take advantage of it. To receive an opposing view, the National Institute of Drug Abuse asked teens around America why they think prescription drugs are overused, and the results were shocking; 62%: “Easy to get from parent's medicine cabinets”, 51%: “They are not illegal drugs”, 49%: “Can claim to have prescription if caught”, 43%: “They are cheap”, 35%: “Safer to use than illegal drugs”, 33%: “Less shame attached to using”, 32%: “Fewer side effects than street drugs”, 25%: “Can be used as study aids”, and 21%: “Parents don't care as much if caught”. I believe the major problem here isn’t the medication, but instead the fact that our nation is extremely uninformed on the “do’s and dont’s” of prescription medication. When “the United States is 5 percent of the world’s population and consumes 75 percent of the the world's prescription drugs” (CDC), there is a problem present, no matter the reason. Clearly, many critics believe the breathtaking amount of pills we consume in America is simply for the better good, but tend to forget the effects that are soon to follow.
In America, it has become a battle to earn a high paying job to cope with the expenses of a typical American. It has become even more of a battle for some people to afford medical prescriptions to keep healthy. Health becomes a crucial issue when discussed among people. No matter what, at one point or another, everyone is going to stand as a victim of the pharmaceutical industry. The bottom line is Americans are paying excessive amounts of money for medical prescriptions. Health-Care spending in the U.S. rose a stunning 9.3% in 2002, which is the greatest increase for the past eleven years. (Steele 46) Many pharmaceutical companies are robbing their clients by charging extreme rates for their products.
Chemoprevention requires treatments that are administered to presumably healthy, asymptomatic subjects who do not have cancer, but do have risk factors associated with an increased probability to cultivate the cancer which the experimental intervention is theorized to condense. So, chemoprevention research involves at-risk research subjects who are neither patients diagnosed with disease, as in treatment trials, or typical healthy volunteers. There is a growing interest and investment in research on cancer chemoprevention. Several major cancer chemoprevention trials have been conducted in the United States, including trials testing the effectiveness of tamoxifen, both alone and later compared to raloxitene, to prevent primary invasive breast cancer; finasteride to prevent prostate cancer; and beta-carotene to prevent lung cancer.
I have chosen to review an article from the Journal of Health Communication. The Journal of Health Communication reports studies both of qualitative and quantitative values for the scholarly and professional individual. It is designed to give concise and ethical reviews of academic research (Scott C. Ratzan). Furthermore, the Journal of Health Communication focuses on promoting the vital life of the individual and the good health of the world’s people with presentation of research for the purpose of better health (Scott C. Ratzan). I choose to review an article which focused on the increased volume of prescription drug advertising directed to consumer, as it has grown tremendously over the past few decades. It has been reported, drug advertisements have experienced a significant increase in the amount of money spent on advertising from $47 million dollars in 1990 to nearly $2.5 billion in 2000 (Frank, Berndt, Donohue, Epstein, & Rosenthal, 2002; M...
There are many risks that affect breast cancer. One of the reasons it is more common, is because we have better medical equipment that detects breast cancer at an earlier stage than before. An estimated 192,370 new cases of breast cancer will occu...
Chemotherapy is the use of chemicals to cure cancer. Chemotherapy is also known as “chemo”. The term for chemo came from the German bacteriologist Paul Ehrlich around the year 1900. He came up with the term when he was examining aniline dyes and arsenicals as possible treatments for diseases such as syphilis. He envisioned “magic bullets” that would be able to target invading organisms but still leave the host unscathed. This goal has been providing therapeutic benefits without many side effects in all areas of drug development. There has been a lot of success with compounds that modulate normal biochemistry within the body.
In the United States, starting from the first breast cancer case in 1930s to today, a woman's lifetime risk of breast cancer increases to one eighth (Gray et al.). Continuously increasing breast cancer rate has caused a lot of concerns among not only ordinary people but also scientists. For decades, scientists have been working on the causes of breast cancer in order to find the corresponding methods of treatment. However, only about 25% of the breast cancer cases got explained (Brody et al.); till today, heredity, lifetime exposure to environmental estrogen (the female sex hormone), and the dietary fat are the only major known causes (“Cover Story: Breast Cancer and Environment”). For the 75% unexplained breast cancers cases, scientists, through various of researches, have come up with several hypothetical breast cancer causes, in which synthetic chemicals and environmental radiations are the major ones.
Breast Cancer is defined as “a group of solid tumor malignancies arising in the tissues of the breast” (Sarah Crawford, Richard Alder, 2013) in human and other mammals. It can happen to both men and women. For women, breast cancer is one of the leading causes of cancer death. According to National Cancer Institute, in the United States, the 2014 estimated new cases and deaths of female from breast cancer are 232,670 and 40,000, respectively. For male, it’s 430 deaths out of 2,360 new cases. From these numbers, we can see that women in the U.S. are greatly affected by breast cancer, thus, it’s not difficult to imagine the impact on a worldwide level. Although these numbers look frightening, people can actually survive from breast cancer if it is detected early and treated properly, so it is extremely important for all of us, especially women, to have a better understanding of breast cancer.
For most, the primary fears associated with cancer are connected to the effects of treatments. If the patient is diagnosed when the cancer is still in the early stages, more than likely surgery is the appropriate treatment. However if the cancer has developed into an advanced stage, a more drastic treatment is necessary.